Obesity, Inflammation, and Insulin Resistance (Q22250939)

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The liver as an immunological organ

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inflammation: the link between insulin resistance, obesity and diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Ceramides in insulin resistance and lipotoxicity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Reduction of blood fibrinolytic activity in diabetes mellitus by insulin.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

FIBRINOLYSIS IN OBESITY

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Statins as anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Fibrinolysis and body bulid. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The mitochondrial uncoupling-protein homologues.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

1 reference

7 January 2021

A new class of obesity genes encodes leukocyte adhesion receptors

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Regulation of fasted blood glucose by resistin

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Aspirin and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Differentiation between obesity and insulin resistance in the association with C-reactive protein

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Going both ways: immune regulation via CD1d-dependent NKT cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Increased oxidative stress in obesity and its impact on metabolic syndrome

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Obesity and diabetes in TNF-alpha receptor- deficient mice

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Metabolic effects of visceral fat accumulation in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Evidence for a potent antiinflammatory effect of rosiglitazone

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Interleukin-6 gene polymorphism and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Salicylates as hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

Resistin, an adipokine with potent proinflammatory properties

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.03.059

7 January 2021